Different Susceptibilities of Postmitotic Checkpoint-proficient and-deficient Balb/3T3 Cells to ICRF-193, a Catalytic Inhibitor of DNA Topoisomerase II

  • NISHIDA Keiko
    Division of Molecular Medicine, Aichi Cancer Center Research Institute
  • SETO Masao
    Division of Molecular Medicine, Aichi Cancer Center Research Institute
  • ISHIDA Ryoji
    Division of Molecular Medicine, Aichi Cancer Center Research Institute

この論文をさがす

収録刊行物

被引用文献 (2)*注記

もっと見る

参考文献 (43)*注記

もっと見る

詳細情報

問題の指摘

ページトップへ